Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
- PMID: 34824058
- PMCID: PMC8620104
- DOI: 10.1183/13993003.02463-2021
Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
Abstract
When indicating ECMO in patients with COVID-19, centre case volume, age, driving pressure and the duration of symptoms (not the length of MV) should be taken into account. Large drainage cannula and high PEEP levels during the first days are recommended.
Conflict of interest statement
Conflict of interest: The authors declare that they have no conflict of interest.
Figures
Comment in
-
ECMO during the COVID-19 pandemic: moving from rescue therapy to more reasonable indications.Eur Respir J. 2022 Feb 10;59(2):2103262. doi: 10.1183/13993003.03262-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 35115345 Free PMC article.